Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Bahrain.
Campus
Campus

There is significant unmet need in the management of PN¹

The clinical objective in PN is to relieve intense itch and heal nodular lesions, which may improve patients’ QoL2-4

A multimodal treatment approach is recommended for PN by a US consensus panel2,

Treatment is selected based on a patient’s clinical presentation, comorbidities, and response to prior treatments and should address both neural and immunologic components of disease, which often requires use of multiple therapeutic agents2,5

  1. Mainly topical therapies
  2. Widespread skin-directed or systemic therapies
  3. Experimental therapies

There remains an unmet need in the management of PN1

References

  1. Qureshi AA, Abate LE, Yosipovitch G, Friedman AJ. A systematic review of evidence-based treatments for prurigo nodularis. J Am Acad Dermatol. 2019;80(3):756-764. 
  2. Elmariah S, Kim B, Berger T, et al. Practical approaches for diagnosis and management of prurigo nodularis: United States expert panel consensus. J Am Acad Dermatol. 2021;84(3):747-760. 
  3. Kowalski EH, Kneiber D, Valdebran M, Patel U, Amber KT. Treatment-resistant prurigo nodularis: challenges and solutions. Clin Cosmet Investig Dermatol. 2019;12:163-172. 
  4. Ständer HF, Elmariah S, Zeidler C, Spellman M, Ständer S. Diagnostic and treatment algorithm for chronic nodular prurigo. J Am Acad Dermatol. 2020;82(2):460-468. 
  5. Williams KA, Huang AH, Belzberg M, Kwatra SG. Prurigo nodularis: pathogenesis and management. J Am Acad Dermatol. 2020;83(6):1567-1575.
Related articles
Mechanism of Prurigo Nodularis Disease

Mechanism of Prurigo Nodularis Disease

In this comprehensive exploration, we delve into the intricate pathophysiology of Prurigo Nodularis (PN), highlighting the pivotal roles of neuronal sensitization, inflammation, and pruritus. This challenging dermatological condition is characterized by dermatological condition histopathologic alterations, including enhanced hypervascularization, epidermal hyperkeratosis, and dermal fibrosis. Explore the connection between PN and the proinflammatory Th2 cytokine IL-13, shedding light on its binding to IL-4R across various skin components.

Read article
Prurigo Nodularis Is A Distinct, Chronic, Neural And Immune- Mediated Skin Disease Characterized By Intense Itch And Nodular Lesions1

Prurigo Nodularis Is A Distinct, Chronic, Neural And Immune- Mediated Skin Disease Characterized By Intense Itch And Nodular Lesions1

Read article
Type 2 Inflammation may play a role in Prurigo Nodularis Pathophysiology1

Type 2 Inflammation may play a role in Prurigo Nodularis Pathophysiology1

Exact pathophysiology of PN is currently not understood. Based on the evolving literature, type 2 inflammation may play a role in PN.

Read article
MAT-BH-2200541/V1/June 2022